Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck
Peng Han(Harbin Medical University), Qingyi Wei(Hainan Normal University), Kouros Owzar(Duke University), Walter T. Lee(Duke University), José P. Zevallos(University of Pittsburgh Medical Center), Jesse D. Troy(Duke Medical Center), Zhensheng Liu(Anhui Provincial Children's Hospital), Hongliang Liu(Fosun Pharma (China)), Qiong Shi(Hebei Medical University), Fengqin Gao(The University of Texas MD Anderson Cancer Center), Erich M. Sturgis(Baylor College of Medicine)
Cited by 9
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655
Detectable clonal mosaicism from birth to old age and its relationship to cancer
|Nature Genetics|2012|598